Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Hydrocortisone Acetate
Therapeutic Area : Gastroenterology
Study Phase : Phase III
Sponsor : Cristcot
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories
Details : Hydrocortisone Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Ulcerative Proctitis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 14, 2020
Lead Product(s) : Hydrocortisone Acetate
Therapeutic Area : Gastroenterology
Highest Development Status : Phase III
Sponsor : Cristcot
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hydrocortisone Acetate
Therapeutic Area : Gastroenterology
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Hydrocortisone Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Hemorrhoids.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 08, 2017
Lead Product(s) : Hydrocortisone Acetate
Therapeutic Area : Gastroenterology
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hydrocortisone Acetate
Therapeutic Area : Gastroenterology
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Efficacy of Hydrocortisone and Lidocaine Treatment of Grade I and II Hemorrhoids
Details : Hydrocortisone Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Hemorrhoids.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 24, 2016
Lead Product(s) : Hydrocortisone Acetate
Therapeutic Area : Gastroenterology
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hydrocortisone Acetate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Parexel
Deal Size : Inapplicable
Deal Type : Inapplicable
Pharmacokinetics and Bioavailability of Hydrocortisone Acetate Suppositories
Details : Hydrocortisone Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 02, 2016
Lead Product(s) : Hydrocortisone Acetate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Parexel
Deal Size : Inapplicable
Deal Type : Inapplicable